All Stories

  1. Response to Commentary on “Risk factors for perinatal and neonatal mortality in cases with congenital anomalies of the kidney and urinary tract: a nested cohort study”
  2. Prune-belly Syndrome: An Update
  3. Risk factors for perinatal and neonatal mortality in cases with congenital anomalies of the kidney and urinary tract: a nested cohort study
  4. Risk factors for early mortality in infants with congenital anomalies of the kidney and urinary tract: a nested cohort study
  5. The Role of Renin-Angiotensin System in Diabetic Nephropathy: An Update
  6. COVID-19 Vaccine Effectiveness and Risk Factors of Booster Failure in 480,000 Patients with Diabetes Mellitus: A Population-Based Cohort Study
  7. Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases
  8. Dental anomalies in a patient with Tyrosinemia type I: first case report in the literature
  9. Oxidative Stress in Renal Health
  10. Efficacy, safety, and biomarker changes of B-cell activating factor- and A proliferation-inducing ligand-targeted therapies in IgA nephropathy: A systematic review and meta-analysis of randomized controlled trials
  11. Expression of immunophenotypic markers in blood mononuclear cells of patients with advanced head and neck squamous cells carcinoma
  12. Inflammatory markers in cerebrospinal fluid in pediatric Brazilian spotted fever with neurological manifestations
  13. Strength Training can Modulate Urinary Adipokine Levels in Healthy Young Males
  14. Kidney transplantation reduces biomarkers of endothelial dysfunction
  15. Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients
  16. A case of suicide secondary to diethylene glycol intentional ingestion
  17. Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis
  18. Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-analysis
  19. Effectiveness of oseltamivir in reducing COVID-19-related in-hospital deaths: A pharmacoepidemiological study
  20. Translation, cross-cultural adaptation and validation of the Short Screening Instrument for Psychological Problems in Enuresis for use in Brazil (SSIPPE-Br)
  21. Potential Role of Novel Cardiovascular Biomarkers in Pediatric Patients with Chronic Kidney Disease
  22. Predictive models of chronic kidney disease progression in pediatric patients
  23. Potential urinary biomarkers in preeclampsia: a narrative review
  24. Natural history of albuminuria in a large cohort of children and adolescents with sickle cell anemia from Brazil
  25. Efficacy and Safety of SGLT2 Inhibitors in Pediatric Patients and Young Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  26. Safety and efficacy of sotagliflozin in patients with type II diabetes mellitus and chronic kidney disease: a meta-analysis of randomized controlled trials
  27. The View of Pediatric Nephrotic Syndrome as a Podocytopathy
  28. Doença renal crônica pediátrica: índices de contagem de células sanguíneas como marcadores de inflamação
  29. Pediatric chronic kidney disease: blood cell count indexes as inflammation markers
  30. Multiple odontogenic keratocysts in a patient with Lowe syndrome: a first case report and literature review
  31. Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil
  32. Bartter-like Syndrome Induced By Tacrolimus in a Renal Transplanted Boy: A Case Report
  33. The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
  34. Acute and Chronic Effects of Strength Training on Plasma Levels of Adipokines in Man
  35. How the COVID-19 pandemic has affected children and adolescents’ sleep habits: a systematic review
  36. Nephrotic Syndrome and Renin-angiotensin System: Pathophysiological Role and Therapeutic Potential
  37. Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials
  38. Use of C-reactive protein to guide the antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
  39. Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome
  40. Renal toxicity caused by diethylene glycol: an overview
  41. Redox Signaling in Chronic Kidney Disease-Associated Cachexia
  42. Maternal risk factors for congenital anomalies of the kidney and urinary tract: A case-control study
  43. Novel Biomarkers for Posterior Urethral Valve
  44. Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years
  45. Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study
  46. Imaging Markers of Neurologic Damage in COVID-19: A Systematic Review
  47. The challenges of chemotherapy adjustment in obese individuals
  48. The use and role of telemedicine in maternal fetal medicine around the world: an up-to-date
  49. Inherited Fanconi syndrome
  50. Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents
  51. Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study
  52. Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials
  53. Machine Learning Algorithms to Predict Outcomes in Children and Adolescents with Covid-19: A Systematic Review
  54. Congenital Solitary Functioning Kidney: A Review
  55. Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil
  56. Immuno-oncology in head and neck squamous cell carcinoma - a narrative review
  57. Nut-enriched energy restricted diet has potential to decrease hunger in women at cardiometabolic risk: a randomized controlled trial (Brazilian Nuts Study)
  58. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy in pediatric patients: a meta-analysis
  59. Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia
  60. Relationship between primary monosymptomatic enuresis and process toilet training: a case-control
  61. Costus spiralis extract restores kidney function in cisplatin-induced nephrotoxicity model: Ethnopharmacological use, chemical and toxicological investigation
  62. Modified Levels of Renin Angiotensin Related Components in the Frontal Cortex and Hippocampus were Associated with Neuroinflammation and Lower Neuroprotective Effects of NGF During Acute Hepatic Encephalopathy in Mice
  63. Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents
  64. The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil
  65. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study
  66. Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date
  67. Evaluation of novel bone metabolism markers in kidney transplant recipients
  68. Relationship between toilet training process and primary nocturnal enuresis in children and adolescents – A systematic review
  69. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study
  70. Renal Toxicity Caused by Diethylene Glycol: an Overview
  71. Multi-population genome-wide association study implicates both immune and non-immune factors in the etiology of pediatric steroid sensitive nephrotic syndrome
  72. Hemostasis and oxidative stress in chronic kidney disease in children and adolescents
  73. Acute Post-Streptococcal Glomerulonephritis in Children: A Comprehensive Review
  74. Use of C-reactive protein to guide antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
  75. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients
  76. Clinical Impact and Risk Factors of Mortality in Hospitalized Children and Adolescents With Hematologic Diseases and COVID-19: An Observational Retrospective Cohort Study
  77. Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil
  78. Risk factors for acute kidney injury after liver transplantation in intensive care unit: a retrospective cohort study
  79. Interactions between the intrarenal dopaminergic and the renin–angiotensin systems in the control of systemic arterial pressure
  80. Are in‐hospital COVID‐19‐related mortality and morbidity in pregnancy associated with gestational age?
  81. The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review
  82. Renin-Angiotensin System in Huntington′s Disease: Evidence from Animal Models and Human Patients
  83. The Need to Study Clinical Outcomes in Children and Adolescents With COVID-19 From Middle- and Low-Income Regions
  84. Nephrogenesis, Renal Function, and Biomarkers in Preterm Newborns
  85. Non-surgical management of vesicoureteral junction obstruction: a case report
  86. Tubular and glomerular biomarkers of renal tissue function in the urine of fetuses with posterior urethral valves
  87. Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review
  88. Potential Role of Adult Hippocampal Neurogenesis in Traumatic Brain Injury
  89. Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives
  90. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants
  91. Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage
  92. Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID-19: an analysis of a nationwide database
  93. Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID ‐19 in Brazil: An analysis of a nationwide database
  94. The Curcumin Supplementation with Piperine Can Influence the Acute Elevation of Exercise-Induced Cytokines: Double-Blind Crossover Study
  95. Risk factors for COVID ‐19‐related mortality in hospitalized children and adolescents with diabetes mellitus: An observational retrospective cohort study
  96. Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
  97. Evaluation of insertion/deletion (I/D) polymorphisms of ACE gene and circulating levels of angiotensin II in congenital anomalies of the kidney and urinary tract
  98. Nephrogenic diabetes insipidus: a comprehensive overview
  99. The potential role of renin-angiotensin system in mild traumatic brain injury
  100. Global scientific production in the pre-Covid-19 Era: An analysis of 53 countries for 22 years
  101. Acute kidney injury in pediatrics: an overview focusing on pathophysiology
  102. Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review
  103. Immunoglobulin A nephropathy in paediatrics: An up‐to‐date
  104. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
  105. Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil – Authors' reply
  106. Glucocorticoid receptor Gene (NR3C1) Polymorphisms and Haplotypes in patients with congenital adrenal hyperplasia
  107. Evaluation of Urinary Tract Dilation Classification System for Prediction of Long-Term Outcomes in Isolated Antenatal Hydronephrosis: A Cohort Study
  108. Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
  109. Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
  110. Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives
  111. An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19
  112. Biomarkers of renal function in preterm neonates at 72 h and 3 weeks of life
  113. Postnatal urinary tract dilatation classification: improvement of the accuracy in predicting kidney injury
  114. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis
  115. Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
  116. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database
  117. Editorial: The Role of the Renin-Angiotensin System in the Central Nervous System
  118. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report
  119. Novel Kidney Injury Biomarkers in A Large Cohort of Children with Sickle Cell Anemia
  120. Traumatic brain injury biomarkers in pediatric patients: a systematic review
  121. Lower limb strength training (LLST) modulates serum and urinary levels of renin angiotensin system molecules in healthy young males
  122. Telomere Shortening and Psychiatric Disorders: A Systematic Review
  123. Attention deficit and hyperactivity disorder and nocturnal enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis
  124. Evaluation of Insertion/deletion (I/D) Polymorphisms of ACE Gene in Congenital Anomalies of The Kidney and Urinary Tract From a Brazilian Pediatric Population
  125. Renovascular hypertension in pediatric patients: update on diagnosis and management
  126. Circulating Angiotensin-(1–7) Is Reduced in Alzheimer’s Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study
  127. Factors Associated with Primary Hypertension in Pediatric Patients: An Up-to-Date
  128. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
  129. Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux
  130. Attention Deficit and Hyperactivity Disorder and Enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis
  131. COVID-19 pandemic and the answer of science: a year in review
  132. COVID-19 and Renal Diseases: An Update
  133. ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats
  134. How is COVID-19 pandemic impacting mental health of children and adolescents?
  135. COVID-19 related coagulopathy: what is known up to now
  136. Emotional, Behavioral, and Psychological Impact of the COVID-19 Pandemic
  137. Hepatorenal syndrome in children: a review
  138. Corrigendum to “Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system” [Heliyon 6 (1) (January 2020) e03208]
  139. 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
  140. Immune-Based Therapies for Traumatic Brain Injury: Insights from Pre-Clinical Studies
  141. Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma
  142. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
  143. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
  144. Acute kidney injury biomarkers in the critically ill
  145. TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation
  146. Análise da força de preensão palmar, sensibilidade cutânea manual e uso funcional das mãos em crianças e adolescentes com doença renal crônica em hemodiálise
  147. ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors
  148. Editorial: Developmental Disorders of the Kidney and Urinary Tract: Recent Insights From Clinical and Molecular Studies
  149. Coronavirus Disease Pandemic Is a Real Challenge for Brazil
  150. Covid-19: the renin–angiotensin system imbalance hypothesis
  151. Bartter’s syndrome: clinical findings, genetic causes and therapeutic approach
  152. Biomarkers in vesicoureteral reflux: an overview
  153. Is SARS-CoV-2 Vertically Transmitted?
  154. Renin–angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis
  155. Urinary tract infection in pediatrics: an overview
  156. Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia
  157. The Renin Angiotensin System and Bipolar Disorder: A Systematic Review
  158. Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade
  159. Association between dyslipidemia and CCL2 in patients undergoing hemodialysis
  160. Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia
  161. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output
  162. Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system
  163. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
  164. Renin-angiotensin system and Alzheimer’s disease pathophysiology: From the potential interactions to therapeutic perspectives
  165. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence
  166. Inflammatory biomarkers in children with cerebral palsy: A systematic review
  167. Renin angiotensin system molecules and nitric oxide local interactions in the adrenal gland of Trypanosoma cruzi infected rats
  168. Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease
  169. Anti-inflammatory effects of C-peptide on kidney of type 1 diabetes mellitus animal model
  170. Urinary tract infection in pediatrics: an overview
  171. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study
  172. Cell‐Derived Microparticles and Von Willebrand Factor in Brazilian Renal Transplant Recipients
  173. A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis
  174. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients
  175. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension
  176. Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine
  177. Distal renal tubular acidosis: genetic causes and management
  178. The protective arm of the renin‐angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  179. A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract
  180. Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease
  181. Interactions between local Renin Angiotensin System and nitric oxide in the brain of Trypanosoma cruzi infected rats
  182. Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  183. Hepatic encephalopathy: Lessons from preclinical studies
  184. Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease
  185. Brazil's endangered postgraduate system
  186. The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  187. Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome
  188. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection
  189. Pediatric lupus nephritis
  190. Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts
  191. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease
  192. Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
  193. A clinical predictive model of renal injury in children with congenital solitary functioning kidney
  194. A clinical predictive model of chronic kidney disease in children with posterior urethral valves
  195. RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders
  196. Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors
  197. Dental Alterations in Renal Tubular Acidosis: Case Reports
  198. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease
  199. Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia
  200. Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
  201. Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals
  202. Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review
  203. The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  204. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis
  205. Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis
  206. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System
  207. Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence
  208. T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome
  209. Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study
  210. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
  211. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
  212. Single Nucleotide Variants in A Family of Monozygotic Twins Discordant for the Phenotype Congenital Megaureter: A Genomic Analysis
  213. Kidney–brain axis inflammatory cross-talk: from bench to bedside
  214. Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  215. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  216. Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules
  217. Bj-PRO-5a and Bj-PRO 10c Found at C-Type Natriuretic Peptide Precursor of Bothrops jararaca Change Renal Function of Hypertensive Rats
  218. Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study
  219. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates
  220. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
  221. Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
  222. Renin angiotensin system in liver diseases: Friend or foe?
  223. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients
  224. Early changes in adipokines from overweight to obesity in children and adolescents
  225. Characterization of an experimental model of progressive renal disease in rats
  226. Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease
  227. Early changes in adipokines from overweight to obesity in children and adolescents
  228. Zika virus challenges for neuropsychiatry
  229. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome
  230. Immunoglobulin A nephropathy: a pathophysiology view
  231. Immune markers in the RASopathy neurofibromatosis type 1
  232. ACE inhibition, ACE2 and angiotensin-(1–7) axis in kidney and cardiac inflammation and fibrosis
  233. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients
  234. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis
  235. Frequência de sobrepeso e obesidade em crianças e adolescentes com autismo e transtorno do déficit de atenção/hiperatividade
  236. Nutritional evaluation of children with chronic cholestatic disease
  237. Nutritional evaluation of children with chronic cholestatic disease
  238. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
  239. Chemokines as Potential Markers in Pediatric Renal Diseases
  240. Uromodulin: a new biomarker of fetal renal function?
  241. Update on the approach of urinary tract infection in childhood
  242. Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis
  243. Update on the approach of urinary tract infection in childhood
  244. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report
  245. Propriedades psicométricas da Escala de Responsividade Social-2 para Transtornos do Espectro Autista
  246. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease
  247. Dental findings in Brazilian patients with Fanconi syndrome
  248. A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome
  249. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update
  250. Anthropometric and Biochemical Profile of Children and Adolescents with Chronic Kidney Disease in a Predialysis Pediatric Interdisciplinary Program
  251. Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients
  252. Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome
  253. Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: A preliminary study
  254. Mas in the Kidney
  255. Chemokines as Potential Markers in Pediatric Renal Diseases
  256. Mas and Inflammation
  257. Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology
  258. Congenital anomalies of the kidney and urinary tract: An embryogenetic review
  259. Angiotensin type 2 receptor gene are associated with ureteropelvic junction obstruction
  260. A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract
  261. PAX2 Polymorphisms and Congenital Abnormalities of the Kidney and Urinary Tract in a Brazilian Pediatric Population: Evidence for a Role in Vesicoureteral Reflux
  262. The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders
  263. Dental Manifestations in Two Patients With Bartter’s Syndrome
  264. Progression of CKD in children
  265. Chemokines as Potential Markers in Pediatric Renal Diseases
  266. Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract
  267. Cognitive alterations in chronic kidney disease: an update
  268. Neuropsychiatric disorders and renal diseases: an update
  269. Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates
  270. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies
  271. Profile and scientific production of Brazilian National Council of Technological and Scientific Development researchers in Pediatrics
  272. Diagnostic Accuracy of Renal Pelvic Dilatation for Detecting Surgically Managed Ureteropelvic Junction Obstruction
  273. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
  274. Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme
  275. Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
  276. Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile
  277. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
  278. Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences
  279. Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging
  280. Autoimmune hepatitis in childhood: The role of genetic and immune factors
  281. Correlation between the Degree of Hydrolysis and the Peptide Profile of Whey Protein Concentrate Hydrolysates: Effect of the Enzyme Type and Reaction Time
  282. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease
  283. Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica
  284. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases
  285. Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo
  286. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study
  287. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis
  288. Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns
  289. Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso
  290. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis
  291. Clinical Course of 822 Children with Prenatally Detected Nephrouropathies
  292. Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria
  293. Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
  294. Current knowledge on esophageal atresia
  295. Diagnostic criteria for autoimmune hepatitis in children: A challenge for pediatric hepatologists
  296. Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies
  297. Newer Doppler echocardiography techniques in assessment of heart function in obese patients
  298. Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
  299. Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter’s Syndrome
  300. ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation
  301. The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease
  302. Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?
  303. Inflamação na doença renal crônica: papel de citocinas
  304. Pesquisadores do Conselho Nacional de Desenvolvimento Científico e Tecnológico na área de Cardiologia
  305. Características clínicas e laboratoriais associadas à nefroangioesclerose hipertensiva confi rmada por biópsia renal
  306. Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
  307. Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies
  308. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups
  309. Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress
  310. Bone disease and cytokines in idiopathic hypercalciuria: a review
  311. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
  312. Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children
  313. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit
  314. Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease
  315. Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
  316. ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats
  317. Is remifentanil an option for premedication for neonatal endotracheal intubation?
  318. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis
  319. Risk Factors for Recurrent Urinary Tract Infections in a Cohort of Patients With Primary Vesicoureteral Reflux
  320. Risk Factors for Early Onset of Diabetic Nephropathy in Pediatric Type 1 Diabetes
  321. Citocinas e quimiocinas no transplante renal
  322. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice
  323. Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria
  324. Molecular Pathophysiology of Renal Tubular Acidosis
  325. Independent risk factors for renal damage in a series of primary vesicoureteral reflux: A multivariate analysis
  326. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis
  327. Renin-angiotensin system in the pathogenesis of liver fibrosis
  328. Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria
  329. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme
  330. The renin–angiotensin system and diabetes: An update
  331. Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program
  332. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
  333. Development of hepatorenal syndrome in bile duct ligated rats
  334. Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients
  335. Early awakening and extubation with remifentanil in ventilated premature neonates
  336. Sedação e analgesia em neonatologia
  337. Avaliação da dor em neonatologia
  338. The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
  339. The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)
  340. Morphine versus remifentanil for intubating preterm neonates
  341. Risk of hypertension in primary vesicoureteral reflux
  342. Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease
  343. Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein
  344. Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies
  345. Predictive factors of chronic kidney disease in severe vesicoureteral reflux
  346. The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
  347. Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome
  348. Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy
  349. Nonpeptide AVE 0991 Is an Angiotensin-(1-7) Receptor Mas Agonist in the Mouse Kidney
  350. New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva’s technique
  351. The renin angiotensin system in childhood hypertension: Selective increase of angiotensin-(1-7) in essential hypertension
  352. Angiotensin-(1–7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors
  353. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
  354. Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7)
  355. Spontaneous improvement of hypertension in multicystic dysplastic kidney: a case report
  356. Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
  357. VISCERAL LARVA MIGRANS AND TROPICAL PYOMYOSITIS: A CASE REPORT
  358. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats
  359. Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats
  360. Renal actions of angiotensin-(1-7)
  361. Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
  362. Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): Evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors
  363. Angiotensins